G-CSF and G-CSF Biosimilars Market Report

Global and Region G-CSF and G-CSF Biosimilars Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：213
  • REPORT CODE：GMM880268
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.

    The report details the trend, potential and market size of G-CSF and G-CSF Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of G-CSF and G-CSF Biosimilarsmarket, defines the market attractiveness level of G-CSF and G-CSF Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of G-CSF and G-CSF Biosimilars industry, describes the types of G-CSF and G-CSF Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global G-CSF and G-CSF Biosimilars market and the development prospects and opportunities of G-CSF and G-CSF Biosimilars industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global G-CSF and G-CSF Biosimilars market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Pfizer

    • Merck & Co

    • Johnson & Johnson

    • AstraZeneca

    • Novartis

    • Sanofi

    • Bayer

    • Amgen

    • Gilead Science

    • Roche

    • AbbVie

    By Type:

    • Blood Disorders

    • Oncology Diseases

    • Chronic And Autoimmune Diseases

    • Growth Hormone Deficiencies

    By End-User:

    • Human Growth Hormone

    • Erythropoietin

    • Monoclonal Antibodies

    • Insulin

    • Interferon

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 G-CSF and G-CSF Biosimilars Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 G-CSF and G-CSF Biosimilars Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 G-CSF and G-CSF Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 G-CSF and G-CSF Biosimilars Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise G-CSF and G-CSF Biosimilars Market Analysis and Outlook to 2022

    • 7.1 Global G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    • 7.2 United States G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    • 7.3 Europe G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    • 7.4 China G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    • 7.5 Japan G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    • 7.6 India G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    • 7.7 South Korea G-CSF and G-CSF Biosimilars Consumption (2017-2022)

    8 Region and Country-wise G-CSF and G-CSF Biosimilars Market Analysis and Outlook to 2028

    • 8.1 Global G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.2 United States G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.3 Europe G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.4 China G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.5 Japan G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.6 India G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.7 South Korea G-CSF and G-CSF Biosimilars Consumption Forecast (2022-2028)

    9 Global G-CSF and G-CSF Biosimilars Market Outlook by Types and Applications to 2022

    • 9.1 Global G-CSF and G-CSF Biosimilars Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oncology Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Chronic And Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Growth Hormone Deficiencies Consumption and Growth Rate (2017-2022)

    • 9.2 Global G-CSF and G-CSF Biosimilars Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Human Growth Hormone Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Interferon Consumption and Growth Rate (2017-2022)

    10 Global G-CSF and G-CSF Biosimilars Market Outlook by Types and Applications to 2028

    • 10.1 Global G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Chronic And Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Growth Hormone Deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Human Growth Hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    11 Global G-CSF and G-CSF Biosimilars Import and Export Analysis (Top 5 Countries)

    • 11.1 Global G-CSF and G-CSF Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global G-CSF and G-CSF Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 G-CSF and G-CSF Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global G-CSF and G-CSF Biosimilars Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer G-CSF and G-CSF Biosimilars Product and Service

    • 14.3 Merck & Co

      • 14.3.1 Merck & Co Company Details

      • 14.3.2 Merck & Co G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck & Co G-CSF and G-CSF Biosimilars Product and Service

    • 14.4 Johnson & Johnson

      • 14.4.1 Johnson & Johnson Company Details

      • 14.4.2 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Product and Service

    • 14.5 AstraZeneca

      • 14.5.1 AstraZeneca Company Details

      • 14.5.2 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AstraZeneca G-CSF and G-CSF Biosimilars Product and Service

    • 14.6 Novartis

      • 14.6.1 Novartis Company Details

      • 14.6.2 Novartis G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novartis G-CSF and G-CSF Biosimilars Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi G-CSF and G-CSF Biosimilars Product and Service

    • 14.8 Bayer

      • 14.8.1 Bayer Company Details

      • 14.8.2 Bayer G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer G-CSF and G-CSF Biosimilars Product and Service

    • 14.9 Amgen

      • 14.9.1 Amgen Company Details

      • 14.9.2 Amgen G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Amgen G-CSF and G-CSF Biosimilars Product and Service

    • 14.10 Gilead Science

      • 14.10.1 Gilead Science Company Details

      • 14.10.2 Gilead Science G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Gilead Science G-CSF and G-CSF Biosimilars Product and Service

    • 14.11 Roche

      • 14.11.1 Roche Company Details

      • 14.11.2 Roche G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Roche G-CSF and G-CSF Biosimilars Product and Service

    • 14.12 AbbVie

      • 14.12.1 AbbVie Company Details

      • 14.12.2 AbbVie G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AbbVie G-CSF and G-CSF Biosimilars Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of G-CSF and G-CSF Biosimilars

    • Figure G-CSF and G-CSF Biosimilars Picture

    • Table Global G-CSF and G-CSF Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global G-CSF and G-CSF Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global G-CSF and G-CSF Biosimilars Consumption by Country (2017-2022)

    • Figure United States G-CSF and G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Table Europe G-CSF and G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure China G-CSF and G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Japan G-CSF and G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure India G-CSF and G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure South Korea G-CSF and G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global G-CSF and G-CSF Biosimilars Consumption Forecast by Country (2022-2028)

    • Figure United States G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure China G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure India G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea G-CSF and G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic And Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormone Deficiencies Consumption and Growth Rate (2017-2022)

    • Figure Global Human Growth Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic And Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormone Deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Growth Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Table Global G-CSF and G-CSF Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline G-CSF and G-CSF Biosimilars Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer G-CSF and G-CSF Biosimilars Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co G-CSF and G-CSF Biosimilars Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson G-CSF and G-CSF Biosimilars Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca G-CSF and G-CSF Biosimilars Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis G-CSF and G-CSF Biosimilars Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi G-CSF and G-CSF Biosimilars Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer G-CSF and G-CSF Biosimilars Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen G-CSF and G-CSF Biosimilars Product and Service

    • Table Gilead Science (Foundation Year, Company Profile and etc.)

    • Table Gilead Science G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Science G-CSF and G-CSF Biosimilars Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche G-CSF and G-CSF Biosimilars Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie G-CSF and G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie G-CSF and G-CSF Biosimilars Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US